Prospectus concerning Precise Biometrics' rights issue is published
The Board of Directors of Precise Biometrics has established a prospectus concerning the forthcoming share issue with preferential right for existing shareholders. The prospectus has been registered by the Swedish Financial Supervisory Authority (SFA) and is available in Swedish at www.precisebiometrics.com/prospectus and www.remium.com.
The prospectus in Swedish can also be received free of charge from Precise Biometrics, Scheelevägen 30, Box 798, 220 07 Lund, Sweden, tel. +46 (0) 46-46 31 11 34 or from Remium AB, Kungsgatan 12-14, 111 35 Stockholm, Sweden tel. +46 (0)8-454 32 00.
For information in English, we refer to Precise Biometrics and Remium.
Important information
The publication or distribution of this press release may in certain jurisdictions be subject to restriction by law, and persons in the jurisdictions where this press release has been published or distributed should inform themselves of and follow such legal restrictions.
This press release may not be made public, published or distributed, either directly or indirectly in the United States, Canada, Japan, New Zealand, South Africa, Australia or any other country where such procedures are subject in full or in part to legal restrictions. Nor may the information in this press release may not be communicated, reproduced or presented in any way that is in conflict with such restrictions. Failure to follow this instruction may involve a breach of the United States Securities Act from 1933 ("Securities Act") or applicable laws in other jurisdictions.
In any EEA Member State that has implemented Directive 2003/71/EC (together with any applicable implementing measures in any Member State, the “Prospectus Directive”) other than Sweden, Denmark and the United Kingdom, this press release is only addressed to and is only directed at qualified investors in that Member State within the meaning of the Prospectus Directive (or are other persons to whom a public offering of securities may lawfully be addressed under the Prospectus Directive).
This press release does not contain or constitute an invitation or offer to acquire, subscribe to or otherwise trade with shares, subscription rights or other securities in Precise Biometrics. The invitation to the persons concerned to subscribe to shares in Precise Biometrics will only take place through the Prospectus that Precise Biometrics publishes through this press release, and the Prospectus contains financial statements and other information on Precise Biometrics’ board of directors and auditors.
Neither the subscription rights, paid subscribed shares or the new shares will be registered in accordance with the Securities Act or any other act in Canada, and may not be transferred or offered for sale in the United States or Canada, or to persons domiciled there, or on behalf of such persons, other than in such exceptional cases where registering in accordance with the Securities Act or other act in Canada is not required.
This press release may contain forward-looking statements. When used in this press release, words such as “evaluate”, “expect” and “intend” are intended to identify forward-looking statements. They may involve risks and uncertainties, including product demand and market acceptance, the effect of economic conditions, the impact of competitive products and pricing, foreign currency exchange rates and other risks. These forward-looking statements reflect the views of the management as of the date made with respect to future events and are subject to risks and uncertainties. All of these forward-looking statements are based on estimates and assumptions made by the management and are believed to be reasonable, though are inherently uncertain and difficult to predict. Actual results or experience could differ materially from the forward-looking statements. Precise Biometrics disclaims any intention or obligation to update these forward-looking statements.
This press release consists of such information that Precise Biometrics AB may be obliged to disclose in accordance with the Swedish Securities Market Act and /or the Financial Instruments Trading Act. The information was submitted for publication on May 3, 2011 at 3:45 p.m CET.
For more information
Thomas Marschall, President and CEO, Precise Biometrics AB
Tel. 46 (0)46 31 11 10 or 46 (0) 734 35 11 10
E-mail thomas.marschall@precisebiometrics.com
Patrik Norberg, CFO, Precise Biometrics AB
Tel. 46 (0)46 31 11 47 or 46 (0) 734 35 11 47
E-mail patrik.norberg@precisebiometrics.com
Precise Biometrics is a market-leading provider of solutions for fingerprint recognition to prove people's identities. With top-of-the-line expertise in fingerprint verification, Precise Biometrics offers fast, accurate and secure authentication of a person.
Its core product, Precise Match-on-Card™, adds value to ID, SIM, enterprise and bank cards as well as systems for access control to buildings, computers and networks. Precise Biometrics serves business and government organizations throughout the world and its technology is licensed to close to 100 million users.
For more information, please visit www.precisebiometrics.com
Tags: